Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3) Peptide

SART3 Reactivity: Human Host: Synthetic BP, BI
Catalog No. ABIN5685508
  • Target See all SART3 products
    SART3 (Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3))
    Origin
    Human
    Source
    • 4
    Synthetic
    Application
    Blocking Peptide (BP), BioImaging (BI)
    Characteristics
    SART3 peptide corresponds to 13 amino acids of SART3.
  • Application Notes
    SART3 Peptide is used for blocking the activity of SART3 antibody . The SART3 antibody ships at 0.5 mg/mL and the SART3 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    SART3 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
    Storage
    -20 °C
    Storage Comment
    Store at -20°C. When reconstituted minimize freezing and thawing.
  • Target
    SART3 (Squamous Cell Carcinoma Antigen Recognized By T Cells 3 (SART3))
    Gene ID
    9733
    NCBI Accession
    NP_055521
    OMIM
    7661952
    UniProt
    Q15020
You are here:
Support